Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development
Cornelia Walther, Karin Mörl, Annette G. Beck‐Sickinger
Journal of Peptide Science (2011) Vol. 17, Iss. 4, pp. 233-246
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
Robert E. Steinert, Christine Feinle‐Bisset, Lori Asarian, et al.
Physiological Reviews (2016) Vol. 97, Iss. 1, pp. 411-463
Open Access | Times Cited: 488
Cyclobutanes in Small‐Molecule Drug Candidates
Marnix R. van der Kolk, Mathilde A. C. H. Janssen, Floris P. J. T. Rutjes, et al.
ChemMedChem (2022) Vol. 17, Iss. 9
Open Access | Times Cited: 138
Neuropeptide Y receptors: how to get subtype selectivity
Xavier Pedragosa-Badia, Jan Stichel, Annette G. Beck‐Sickinger
Frontiers in Endocrinology (2013) Vol. 4
Open Access | Times Cited: 153
Regulators of synaptic transmission: Roles in the pathogenesis and treatment of epilepsy
Pablo M. Casillas‐Espinosa, Kim L. Powell, Terence J. O’Brien
Epilepsia (2012) Vol. 53, Iss. s9, pp. 41-58
Open Access | Times Cited: 137
Peptides And Peptide Conjugates: Therapeutics On The Upward Path
Verena M. Ahrens, Kathrin Bellmann‐Sickert, Annette G. Beck‐Sickinger
Future Medicinal Chemistry (2012) Vol. 4, Iss. 12, pp. 1567-1586
Closed Access | Times Cited: 135
Emerging neuropeptide targets in inflammation: NPY and VIP
Bindu Chandrasekharan, Behtash Ghazi Nezami, Shanthi Srinivasan
AJP Gastrointestinal and Liver Physiology (2013) Vol. 304, Iss. 11, pp. G949-G957
Open Access | Times Cited: 134
The Role of Gut Hormone Peptide YY in Energy and Glucose Homeostasis: Twelve Years On
Sean Manning, Rachel L. Batterham
Annual Review of Physiology (2013) Vol. 76, Iss. 1, pp. 585-608
Open Access | Times Cited: 117
Neuropeptides in epilepsy
Stjepana Kovac, Matthew C. Walker
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 467-475
Closed Access | Times Cited: 107
Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors
Tingting Tang, Qiuxiang Tan, Shuo Han, et al.
Science Advances (2022) Vol. 8, Iss. 18
Open Access | Times Cited: 39
Peptide‐Templated Acyl Transfer: A Chemical Method for the Labeling of Membrane Proteins on Live Cells
Ulrike Reinhardt, Jonathan Lotze, Sarah Zernia, et al.
Angewandte Chemie International Edition (2014) Vol. 53, Iss. 38, pp. 10237-10241
Closed Access | Times Cited: 82
Single Cell Peptide Heterogeneity of Rat Islets of Langerhans
Erik T. Jansson, Troy J. Comi, Stanislav S. Rubakhin, et al.
ACS Chemical Biology (2016) Vol. 11, Iss. 9, pp. 2588-2595
Open Access | Times Cited: 75
Emerging therapeutic potential for peptide YY for obesity-diabetes
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Peptides (2018) Vol. 100, pp. 269-274
Closed Access | Times Cited: 62
NPY and Gene Therapy for Epilepsy: How, When,... and Y
Stefano Cattaneo, Gianluca Verlengia, Pietro Marino, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 13
Open Access | Times Cited: 40
Structural basis for ligand recognition of the neuropeptide Y Y2 receptor
Tingting Tang, Christin Hartig, Qiuru Chen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Kylie S. Chichura, Clinton Elfers, Therese S. Salameh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 5
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis
Hongyu Liu, Huimin Xiao, Sufen Lin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Variant screening of PYY 3–36 leads to potent long-acting PYY analogs with superior Y 2 receptor selectivity
Søren Østergaard, Carsten Jessen, Johan F. Paulsson, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 791
Closed Access
Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y
Petra Massoner, Karl Kugler, Karin Unterberger, et al.
PLoS ONE (2013) Vol. 8, Iss. 2, pp. e55207-e55207
Open Access | Times Cited: 48
Replacement of Thr32 and Gln34 in the C-Terminal Neuropeptide Y Fragment 25–36 by cis-Cyclobutane and cis-Cyclopentane β-Amino Acids Shifts Selectivity toward the Y4 Receptor
Łukasz Berlicki, Melanie Kaske, Raquel Gutiérrez‐Abad, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 21, pp. 8422-8431
Closed Access | Times Cited: 47
Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes
Luis E. Gimenez, Stefanie Babilon, Lizzy Wanka, et al.
Cellular Signalling (2014) Vol. 26, Iss. 7, pp. 1523-1531
Open Access | Times Cited: 46
PYY3–36: Beyond food intake
Ulrike Weber‐Stadlbauer, Stephen C. Woods, Wolfgang Langhans, et al.
Frontiers in Neuroendocrinology (2014) Vol. 38, pp. 1-11
Open Access | Times Cited: 45
Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Current Opinion in Endocrinology Diabetes and Obesity (2020) Vol. 28, Iss. 2, pp. 253-261
Open Access | Times Cited: 37
Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread
Dawid Sigorski, Wojciech Wesołowski, Agnieszka Gruszecka, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5803-5822
Open Access | Times Cited: 19
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery
Leona Wagner, Raik Wolf, Ulrike Zeitschel, et al.
Journal of Neurochemistry (2015) Vol. 135, Iss. 5, pp. 1019-1037
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top